Enzymes Inhibition Determination Service
MtoZ Biolabs provides comprehensive Enzymes Inhibition Determination Service for drug discovery, biochemical research, and mechanistic studies. Our service evaluates how small molecules, peptides, biologics, natural products, or other research compounds modulate the activity of diverse enzyme families. MtoZ Biolabs delivers experimental enzymatic inhibition testing across multiple assay formats using biochemical, cell based, and UPLC-MS based readouts.
Background
Enzymes are central to nearly every biological process. They regulate metabolic pathways, activate and deactivate signaling cascades, drive protein modification, control transcriptional programs, and catalyze essential chemical reactions. Dysregulation of enzymatic activity is linked to cancer, neurodegeneration, infection, cardiovascular disease, metabolic disorders, immune dysfunction, and many other human diseases. Understanding how potential therapeutics influence enzyme activity is a critical requirement in modern drug discovery.
Enzymes inhibition determination is the systematic assessment of how a compound reduces, blocks, or shifts the catalytic activity of a specific enzyme. These evaluations reveal potency, specificity, mechanism of action, kinetic behavior, and inhibition constants. Experimental inhibition studies play a crucial role in lead optimization, safety evaluation, off target profiling, and mechanism elucidation.
Enzymes Inhibition Determination Service at MtoZ Biolabs
At MtoZ Biolabs, we conduct systematic inhibition studies using human liver microsomes and primary hepatocytes. Test compounds are incubated with the selected enzyme system at appropriate concentrations, followed by quantitative UPLC-MS based measurement of metabolite formation or substrate depletion. The resulting data enable accurate determination of inhibition potency and kinetic behavior, including IC50 and Ki when required.
Our service portfolio spans major enzymatic pathways relevant to drug metabolism:
💠Cytochrome P450 Enzyme (CYP) Inhibition Studies
Evaluation of inhibition against key cytochrome P450 isoforms to assess metabolic liability and potential interaction risks.
💠UDP Glucuronosyltransferase Enzyme (UGT) Inhibition Studies
Assessment of inhibition effects on major UDP glucuronosyltransferase isoforms involved in conjugative metabolism.
💠Flavin-Containing Monooxygenase (FMO) Inhibition Studies
Profiling of inhibition toward flavin containing monooxygenase mediated pathways.
💠Monoamine Oxidase (MAO) Inhibition Studies
Measurement of inhibition of monoamine oxidase activity, important for compounds structurally similar to amines or neurotransmitter like substrates.
💠N-Acetyltransferase (NAT) Inhibition Studies
Analysis of N-acetyltransferase inhibition to identify interference with acetylation dependent metabolic routes.
💠Aldehyde Oxidase (AOX) Inhibition Studies
Determination of inhibition of aldehyde oxidase, a pathway increasingly recognized for its significance in peptide and non peptide drug metabolism.
💠Carboxylesterase (CE) Inhibition Studies
Characterization of inhibition of CE mediated hydrolysis reactions that influence the activation or clearance of ester containing compounds.
💠Aromatase (CYP19A1) Inhibition Studies
Screening for inhibition of aromatase activity, supporting endocrine related drug discovery or safety evaluations.
Across all assay formats, MtoZ Biolabs provides flexible study design, selection of system specific probe substrates, and a range of inhibitor concentrations to develop detailed inhibition profiles.
Why Choose MtoZ Biolabs
✔️Extensive Enzyme Panel Coverage
We provide inhibition studies across CYP, UGT, FMO, MAO, NAT, AOX, CE, and other relevant metabolic enzymes, enabling comprehensive assessment of interaction risks.
✔️High-Quality In Vitro Systems
Our assays utilize human liver microsomes, hepatocytes, recombinant enzymes, and isoform-specific substrates to ensure physiologically relevant and reliable inhibition data.
✔️Advanced Analytical Platforms
Sensitive UPLC-MS/MS platform allowa precise measurement of metabolite formation.
✔️Project-Tailored Study Design
Protocols, enzyme selections, substrate concentrations, and incubation conditions are customized according to compound properties and study objectives.
✔️Experienced Scientific Team
Our specialists provide expert interpretation of enzyme inhibition mechanisms, kinetic behavior, and structure related inhibition patterns.
Applications of Enzymes Inhibition Determination Service
Our Enzymes Inhibition Determination Service supports a broad range of research and development needs across drug discovery and preclinical evaluation.
1. Drug Interaction Risk Assessment
Used to determine whether candidate compounds inhibit major or minor metabolic enzymes, helping identify potential drug drug interaction liabilities early in development.
2. Metabolic Pathway Characterization
Supports the identification of metabolic routes by clarifying which enzymatic systems are affected by the test compound.
3. Lead Optimization and Structure Refinement
Provides inhibition profiles that guide medicinal chemists in optimizing molecular structures to reduce metabolic liabilities and improve safety margins.
4. Preclinical Safety Evaluation
Generates enzyme inhibition data needed to support absorption, distribution, metabolism, and toxicity assessments during early pharmacokinetic studies.
FAQ
Q1: What types of samples are suitable?
This service accepts both purified test compounds and biologically derived samples, including peptides, small molecules, and candidate drugs in appropriate solvent systems.
Q2: How should I prepare my samples?
Provide samples at known concentration and purity, dissolved in MS compatible solvents such as water, PBS, or low-percentage organic buffer. For biologically derived materials, clarify by centrifugation or filtration to remove particulates.
For more information, please refer to Sample Submission Guidelines for Proteomics and Sample Submission Guidelines for Metabolomics.
Q3: What is the service general workflow?
Q4: What data formats are provided?
We deliver quantitative results and inhibition curves in PDF reports, processed datasets in Excel or CSV, and raw LC-MS/MS files when applicable. Other formats can be supplied if your project requires them.
Start Your Project with MtoZ Biolabs
Contact us to discuss your experimental design or request a quote. Our technical specialists are available to provide a free business assessment.
How to order?
